Eagle Pharmaceuticals
EGRX
#10068
Rank
NZ$21.42 M
Marketcap
$1.65
Share price
-5.50%
Change (1 day)
-81.15%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): NZ$56.84 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2022 the company made an earning of NZ$0.11 Billion, an increase over its 2021 earnings that were of -NZ$5.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) NZ$56.84 M-50.67%
2022 NZ$0.11 B-2361.45%
2021 -NZ$5.1 Million-111.53%
2020 NZ$44.17 M2.31%
2019 NZ$43.17 M-32.89%
2018 NZ$64.33 M-50.35%
2017 NZ$0.12 B38.63%
2016 NZ$93.47 M1966.43%
2015 NZ$4.52 M-111.46%
2014 -NZ$39.49 Million282.82%
2013 -NZ$10.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$30.51 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.68 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$23.86 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$0.5 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$8.06 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.18 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.66 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA